Oral 25-hydroxyvitamin D3 and COVID-19

NCT04386850 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

1500

Enrollment

OTHER

Sponsor class

Conditions

COVID 19

Interventions

DRUG: Oral 25-Hydroxyvitamin D3

Sponsor

Tehran University of Medical Sciences

Collaborators

[object Object]